Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dropping Pill for CHD with Hypertension
NCT01825759Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 4 trial of Compound Danshen in coronary heart disease (CHD), essential hypertension, sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
Compound Danshen
03
Conditions
coronary heart disease (CHD)essential hypertension
Beyond the preview
Go deeper on NCT01825759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825759.